Bristol Myers Squibb’s Cancer Drug Just Doubled Survival Time Without Progression — Here’s Why It Matters
· fool.com · popularity 29/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at fool.com →
Summary
The medication, which is being developed with the company's Chinese partner, did very well in a late-stage clinical trial. Good news from the clinic …
Found in: Investing, The Motley Fool. Rating basis: single outlet; outlet tier 2 (unlisted); 2 feeds; listed 2 times; feed position 5.